Funded Tech Companies
Hopewell Therapeutics
Hopewell Therapeutics is a biopharmaceutical growth company, based in Woburn. Venture investment and financing was provided by WS Investment, 5Y Capital and IMO Ventures.
Company Overview
Company Name
Hopewell Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
216 W Cummings Park
Woburn, MA 01801
USA
Woburn, MA 01801
USA
Phone
Website
Email Address
Company Background Information
Overview
Hopewell Therapeutics is discovering, synthesizing and developing the next generation of tissue-targeted lipid nanoparticles (ttLNPs) to bring genomic medicines to patients. We are pursuing opportunities to redefine the non-viral delivery space for novel genomic medicines by designing systemically administered LNPs to specifically target extrahepatic tissues and cells throughout the body. Hopewell has built a robust intellectual property portfolio with an expansive library of ionizable lipids and has established partnerships with several industry leading companies. We are developing our own internal pipeline, initially targeting diseases of the lung, while concurrently exploring the potential of our ttLNP platform for patients with unmet needs in oncology, infectious diseases, rare genetic diseases and neurological disorders.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/7/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thomas Hennessey
Chief Scientific Officer
Kate Zhang
Founder
Qiaobing Xu
Company Investors
Browse more funded tech companies:
Share this article
About Our Venture Capital Transactions Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs